← Back to Search

Antifungal

SKX-16 (Luliconazole 10% Solution) for Toenail Fungus

Phase 1
Waitlist Available
Research Sponsored by SATO Pharmaceutical Co., Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 days
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a medicated solution with 10% Luliconazole applied daily for about a month in adults with a toenail fungal infection. The solution aims to kill the fungus causing the infection. Luliconazole is a new treatment being developed in the USA for skin and nail infections.

Eligible Conditions
  • Toenail Fungus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
PK parameters for the systemic absorption of luliconazole - AUC0-24h
PK parameters for the systemic absorption of luliconazole - AUC0-∞
PK parameters for the systemic absorption of luliconazole - Cmax
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: SKX-16 (Luliconazole 10% Solution)Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

SATO Pharmaceutical Co., Ltd.Lead Sponsor
1 Previous Clinical Trials
134 Total Patients Enrolled
Brent Clary, CCRCStudy ChairClinical Research Coordinator J&S Studies, Inc.
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top